Research output: Contribution to journal › Article › peer-review
Antimicrobial activity of 5-membered nitroheteroaromatic compounds beyond nitrofurans and nitroimidazoles : Recent progress. / Kalinin, Stanislav; Vedekhina, Tatiana; Paramonova, Polina; Krasavin, Mikhail.
In: Current Medicinal Chemistry, Vol. 28, No. 29, 16.02.2021, p. 5926-5982.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Antimicrobial activity of 5-membered nitroheteroaromatic compounds beyond nitrofurans and nitroimidazoles
T2 - Recent progress
AU - Kalinin, Stanislav
AU - Vedekhina, Tatiana
AU - Paramonova, Polina
AU - Krasavin, Mikhail
N1 - Stanislav Kalinin, Tatiana Vedekhina, Polina Paramonova and Mikhail Krasavin*, Antimicrobial Activity of 5-membered Nitroheteroaromatic Compounds beyond Nitrofurans and Nitroimidazoles: Recent Progress, Current Medicinal Chemistry 2021; 28(29) . https://dx.doi.org/10.2174/0929867328666210216114838
PY - 2021/2/16
Y1 - 2021/2/16
N2 - The last decade has been characterized by the development and approval of pretomanid and delamanid, which are nitroimidazole based drugs for multidrug -resistant tuberculosis. This attracted renewed attention to the nitroheterocyclic scaffolds as a source of safe and efficient antimicrobial agents. While the primary focus is still on nitrofurans and nitroimidazoles, well known as bioreducible prodrugs, a number of studies have been published on other 5-membered nitroheteroaromatic compounds. The latter not only show promising antimicrobial activity but also demonstrate modes of action different from the conventional reductive activation of the nitro group. Considering the potential of these efforts to impact the continuing race against drug-resistant pathogens, herein we review non-furan/imidazole-based 5-membered nitroheteroaromatics investigated as antimicrobial agents in 2010-2020.
AB - The last decade has been characterized by the development and approval of pretomanid and delamanid, which are nitroimidazole based drugs for multidrug -resistant tuberculosis. This attracted renewed attention to the nitroheterocyclic scaffolds as a source of safe and efficient antimicrobial agents. While the primary focus is still on nitrofurans and nitroimidazoles, well known as bioreducible prodrugs, a number of studies have been published on other 5-membered nitroheteroaromatic compounds. The latter not only show promising antimicrobial activity but also demonstrate modes of action different from the conventional reductive activation of the nitro group. Considering the potential of these efforts to impact the continuing race against drug-resistant pathogens, herein we review non-furan/imidazole-based 5-membered nitroheteroaromatics investigated as antimicrobial agents in 2010-2020.
KW - 1,3,4-OXADIAZOLE DERIVATIVES
KW - 2
KW - 2-COMPONENT SIGNAL-TRANSDUCTION
KW - 4-triazoles
KW - DRUGS
KW - GIARDICIDAL ACTIVITY
KW - HELICOBACTER-PYLORI
KW - IN-VITRO
KW - Nitroaromatic heterocycles
KW - OLD ANTIBIOTICS
KW - REDUCTIVE ACTIVATION
KW - RESEARCH-AND-DEVELOPMENT
KW - TRICHOMONAS-VAGINALIS
KW - antimicrobial agents
KW - drug-resistant pathogens
KW - microbial enzymes
KW - nitro-1
KW - nitro-thiazoles
KW - nitroisoxazoles
KW - nitropyrroles
KW - nitrothiophenes
KW - Humans
KW - Nitroimidazoles/pharmacology
KW - Nitrofurans/pharmacology
KW - Anti-Infective Agents/pharmacology
KW - Prodrugs
KW - Tuberculosis, Multidrug-Resistant
KW - Antitubercular Agents/pharmacology
UR - http://www.scopus.com/inward/record.url?scp=85115635200&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/a691db79-e034-3153-80e8-1a9ed2025042/
U2 - 10.2174/0929867328666210216114838
DO - 10.2174/0929867328666210216114838
M3 - Article
C2 - 33593249
VL - 28
SP - 5926
EP - 5982
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
SN - 0929-8673
IS - 29
ER -
ID: 85062562